Lyell Immunopharma Statistics
Total Valuation
LYEL has a market cap or net worth of $251.09 million. The enterprise value is $9.35 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
Earnings Date | Nov 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
LYEL has 19.21 million shares outstanding. The number of shares has increased by 11.19% in one year.
Current Share Class | 19.21M |
Shares Outstanding | 19.21M |
Shares Change (YoY) | +11.19% |
Shares Change (QoQ) | +0.26% |
Owned by Insiders (%) | 2.60% |
Owned by Institutions (%) | 32.47% |
Float | 12.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4,184.84 |
Forward PS | n/a |
PB Ratio | 0.65 |
P/TBV Ratio | 0.84 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 155.81 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.65, with a Debt / Equity ratio of 0.18.
Current Ratio | 7.65 |
Quick Ratio | 7.50 |
Debt / Equity | 0.18 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.59% and return on invested capital (ROIC) is -26.91%.
Return on Equity (ROE) | -76.59% |
Return on Assets (ROA) | -25.39% |
Return on Invested Capital (ROIC) | -26.91% |
Return on Capital Employed (ROCE) | -60.58% |
Revenue Per Employee | $200 |
Profits Per Employee | -$1.10M |
Employee Count | 300 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.90% in the last 52 weeks. The beta is -0.20, so LYEL's price volatility has been lower than the market average.
Beta (5Y) | -0.20 |
52-Week Price Change | -41.90% |
50-Day Moving Average | 10.88 |
200-Day Moving Average | 11.46 |
Relative Strength Index (RSI) | 71.58 |
Average Volume (20 Days) | 25,085 |
Short Selling Information
The latest short interest is 132,974, so 0.69% of the outstanding shares have been sold short.
Short Interest | 132,974 |
Short Previous Month | 188,200 |
Short % of Shares Out | 0.69% |
Short % of Float | 1.10% |
Short Ratio (days to cover) | 2.04 |
Income Statement
In the last 12 months, LYEL had revenue of $60,000 and -$331.40 million in losses. Loss per share was -$23.52.
Revenue | 60,000 |
Gross Profit | 60,000 |
Operating Income | -211.15M |
Pretax Income | -210.26M |
Net Income | -331.40M |
EBITDA | -194.87M |
EBIT | -211.15M |
Loss Per Share | -$23.52 |
Full Income Statement Balance Sheet
The company has $276.79 million in cash and $55.11 million in debt, giving a net cash position of $241.74 million or $12.58 per share.
Cash & Cash Equivalents | 276.79M |
Total Debt | 55.11M |
Net Cash | 241.74M |
Net Cash Per Share | $12.58 |
Equity (Book Value) | 298.92M |
Book Value Per Share | 20.16 |
Working Capital | 245.31M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$171.48 million and capital expenditures -$517,000, giving a free cash flow of -$172.00 million.
Operating Cash Flow | -171.48M |
Capital Expenditures | -517,000 |
Free Cash Flow | -172.00M |
FCF Per Share | -$8.95 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -351,916.67% |
Pretax Margin | -552,328.33% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LYEL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.19% |
Shareholder Yield | -11.19% |
Earnings Yield | -131.98% |
FCF Yield | -68.50% |
Analyst Forecast
The average price target for LYEL is $15.00, which is 14.24% higher than the current price. The consensus rating is "Sell".
Price Target | $15.00 |
Price Target Difference | 14.24% |
Analyst Consensus | Sell |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:20.
Last Split Date | Jun 2, 2025 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
LYEL has an Altman Z-Score of -4.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.6 |
Piotroski F-Score | 1 |